Header image

Session D: Oral Abstracts

Tracks
.
Wednesday, September 6, 2017
1:00 PM - 2:20 PM
Manhattan Ballroom

Speaker

Dr. Samantha Young
Internal Medicine Resident (PGY 4)
University Of British Columbia

Hepatitis C Cascade of Care among People who Inject Drugs in Vancouver, Canada

1:00 PM - 1:15 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Dr. Samantha Young is General Internal Medicine fellow at the University of British Columbia.
Dr Jenny Iversen
Early Career Fellow
Kirby Institute

Ten-Fold Increase in HCV Treatment Uptake among People who Inject Drugs Following Broad Access to DAA Therapies in Australia

1:15 PM - 1:30 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Jenny holds an NHMRC Early Career Fellowship. She has worked in the harm reduction sector since the early 1990s, previously as a health service manager and as a policy analyst at the NSW Ministry of Health. Jenny oversees coordination of surveillance projects within the viral hepatitis epidemiology and prevention program at the Kirby Institute.
Nick Scott
Econometrician
Burnet Institute

Reaching Hepatitis C Virus Elimination Targets Requires Health System Interventions to Enhance the Care Cascade

1:30 PM - 1:45 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Dr Nick Scott is an Econometrician at the Burnet Institute. Here he uses mathematical and economic models to inform policy decisions in order to translate research into practice.
Dr Hannah Fraser
Senior Research Associate In Infectious Disease Mathematical Modelling
University Of Bristol

Cost-Effectiveness of Scaling Up HCV Prevention, Testing and Treatment Interventions among People who Inject Drugs in the US

1:45 PM - 2:00 PM

Abstract

Biography

Dr Hannah Fraser has a PhD in mathematical biology and has been working at the University of Bristol since October 2014. At Bristol is working on dynamic modelling of hepatitis C in people who inject drugs, modelling both current intervention strategies and projecting the impact of increased interventions and treatments in the future.
Ms Sahar Bajis
Phd Candidate
The Kirby Institute, UNSW Sydney, Australia

Interventions to Enhance Testing, Linkage-to-Care and Treatment Uptake for Hepatitis C Infection among People who Inject Drugs: A Systematic Review

2:00 PM - 2:05 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Sahar Bajis is a PhD Candidate in the Viral Hepatitis Clinical Research Program at The Kirby Institute, UNSW Sydney, Australia.
Miss Heather Valerio
Research Assistant
Glasgow Caledonian University, Health Protection Scotland

Poor Awareness of Hepatitis C Virus Antiviral Effectiveness among People who Actively Inject Drugs in the Direct-Acting Antiviral Era

2:05 PM - 2:10 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Heather Valerio received her masters in public health from the University of Glasgow and has since joined the Blood Borne Virus research team at Glasgow Caledonian University, in collaboration with Health Protection Scotland, as an early career epidemiologist. Her principle areas of interest are hepatitis C virus treatment, outcomes, and post-treatment management.
Agenda Item Image
PhD Elisa Martró
Research group leader
Germans Trias i Pujol University Hospital and Research Institute

A One-Step Diagnosis Algorithm Reveals High Burden of Hepatitis C among People who Inject Drugs in Spain and the Urgency for Improved Linkage-to-Care

2:10 PM - 2:15 PM

Abstract

Speaker Presentation

Biography

As a young researcher, Elisa MartrĂ³ led the Research Group on Clinical Virology and New Diagnostic Approaches at IGTP since 2010, which is mainy focussed on hepatitis C virus. Her 18-year multidisciplinary research training includes a clinical service (Microbiology Service at Germans Trias i Pujol University Hospital, a tertiary care hospital), a prestigious research center on infectious diseases (two-year predoctoral stay at the Centers for Disease Control and Prevention, CDC, Atlanta GA), and a center on HIV/STIs epidemiological research (CEEISCAT).
Ms Margaret O'Sullivan
Clinical Nurse Specialist Community Care
Brighton And Sussex Nhs

Project ITTREAT (Integrated Community Based Test-stage and TREAT) HCV Service for People Who Inject Drugs (PWID)

2:15 PM - 2:20 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Ms Margaret O'Sullivan is a qualified General Nurse and a Registered Mental Health Nurse. I worked in substance misuse in South London, areas which were socioeconomically deprived with a vulnerable client group. Margaret recognized that the physical health needs of this client group were not been met. Initially she worked with Kings College Hospital setting up a community Hepatitis clinic in London before moving to Brighton where Margaret O'Sullivan now delivers a nurse led community hepatitis clinic in a substance misuse service.
loading